Impact Fusion International Announced Today That It Has Reduced Its Long Term Debt by 42%
NAPOLEONVILLE, LA / ACCESSWIRE / October 13, 2021 / Impact Fusion International, Inc. (OTC PINK:IFUS)The Company is pleased to announce...
Year: 2021
Nexa Acquires Answering Services Division of Crocker Communications
With the acquisition, Nexa builds upon its leadership position in the healthcare and medical answering services category PHOENIX--(BUSINESS WIRE)--#answeringservices--Nexa Receptionists...
NextGen Healthcare Announces 2021 Annual Meeting Results
Shareholders Approve the Company’s Reincorporation into Delaware and the Elimination of Cumulative Voting in the Election of Directors Shareholders Elect...
Rritual Superfoods Goes Prime on Amazon Store in USA
Amazon Store and Prime Strategy Maximized with Orca Pacific Partnership Rritual Brand Being Scaled Aggressively Deploying Unmatched Expertise and Technology...
NOVO Health’s Independent Providers Take Advantage of New Cloud-Based Epic EHR Installation to Fuel Innovation and Better Patient Care
NOVO Health Technology Group, Focus Solutions and Medix Technology partner to create a cloud deployment of Epic EHR on Microsoft...
Ōmcare joins fellow home health leaders to discuss the future of care
MINNEAPOLIS--(BUSINESS WIRE)--Ōmcare will join leaders in home health for the 5th Annual ConVerge2Xcelerate 2021 Symposium (#ConV2X) held November 9 –...
Longeviti Welcomes Renowned Neurosurgeon, Leading Cerebral Expert, Dr. David Langer as New Chief Medical Officer
BALTIMORE--(BUSINESS WIRE)--#CNS2021--Longeviti Neuro Solutions, developer of the first low-profile intracranial devices that meet the functional and reconstructive needs of brain...
Health Advance Inc Awarded Distributorship for Government Approved COVID Rapid Test
Health Advance Commercial Activity Picks Up PaceNEW YORK, NY / ACCESSWIRE / October 13, 2021 / Health Advance, Inc (OTC...
Black Duck Software Founder Joins Hyka Pre-Seed Round to Help Break Down the Barriers to Access Treatments at the Forefront of Psychiatry
BOSTON, MA / ACCESSWIRE / October 13, 2021 / Hyka, a healthtech start-up, announced today that prominent investor and entrepreneur,...
Novamind Granted DEA Licenses for Psilocybin Research
Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substancesTORONTO, ON / ACCESSWIRE / October 13,...
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
SHELTON, CT / ACCESSWIRE / October 13, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed...
HealthEquity Releases 15th Edition of HSA Guidebook to Commemorate HSA Awareness Day
Free, educational resource newly updated for open enrollmentDRAPER, Utah, Oct. 13, 2021 (GLOBE NEWSWIRE) -- HealthEquity (NASDAQ: HQY) is releasing...
Syapse Senior People Manager Recognized as 2021 WellBeyond Leader of the Year for Emerging Companies While the Company Takes Home Three Comparably Awards
Syapse has been recognized by its employees as a leader in company happiness, work-life balance, and perks and benefitsSAN FRANCISCO,...
CohBar Announces CB4211 Phase 1a/1b Results Selected for Late Breaker Presentation at The Liver Meeting® 2021
MENLO PARK, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Cosmetic Plastic Surgery Institute: Dr. Mowlavi Receives a Trademark for DrLaguna, Recognized for Exceptional Services to Cosmetic Plastic Surgery
Laguna Beach, CA, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Across the globe, there are a tremendous amount of cosmetic plastic...
FDA Authorizes Sorrento Phase 2 Trial of Epidural Resiniferatoxin for the Orphan Indication of Control of Intractable Cancer Pain
Phase 2 trial of resiniferatoxin (RTX) to proceed following clearance from FDA.The decision is supported by the Phase 1 data...
Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm in Metastatic Breast Cancer
-- Enobosarm is a novel targeted hormone drug to be evaluated in the 3rd line treatment of androgen receptor positive...
SCYNEXIS to Present Pooled Data Analysis Results Demonstrating Consistent Efficacy and Safety Outcomes Across Two Phase 3 VANISH Clinical Trials of Oral Ibrexafungerp Therapy for Vaginal Yeast Infection at October Medical Conferences
JERSEY CITY, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Sharps Compliance Announces First Quarter Fiscal 2022 Conference Call and Webcast
HOUSTON, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its first...
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health
TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic...